Nabilone clinical trials
Nabilone is named as an intervention in 2 current clinical trials in our USA and Canada registers. 2 are recruiting patients now. All registered phases are Phase 3. The sponsor with the most trials is PleoPharma, Inc (1). The most-studied condition is Cannabis Withdrawal.
Where Nabilone is approved
All regulators →Of the three regulators tracked here, the first to approve Nabilone was the US, on 26 Dec 1985.
- 1 EU orphan designation, most recently for treatment of amyotrophic lateral sclerosis (16 Jan 2011, negative)
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Nabilone
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Nabilone works
All drug targets →- Cannabinoid CB1 receptor agonist AgonistTarget: CNR1 cannabinoid receptor 1✓ In ChEMBL and the Guide to Pharmacology
- AgitationPhase 3
- Alzheimer diseasePhase 3
- Parkinson diseasePhase 3
- PruritusPhase 3
- Neuropathic painPhase 3
- AnorexiaPhase 2/3
- Cannabis dependencePhase 2/3
- Non-small cell lung carcinomaPhase 2/3
- IrritabilityPhase 2
- SpasticityPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL2218896, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 9071, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Nabilone
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Nabilone
- ChEMBL
- CHEMBL2218896
- PubChem CID
- 39860
- CAS number
- 56496-90-3
- Wikidata
- Q27087822
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Nabilone
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Nabilone for Agitation Blinded Intervention Trial
NCT04516057 · ClinicalTrials.gov ↗ · Alzheimer Disease, Agitation
|
Phase 3 | Recruiting | Sunnybrook Health Sciences Centre | Canada |
|
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
NCT07644052 · Cannabis Withdrawal
|
Phase 3 | Recruiting | PleoPharma, Inc | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Nabilone
3 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| PleoPharma, Inc | 1 |
| Sunnybrook Health Sciences Centre | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 1 |
| Clinical trials in Canada | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Nabilone trials
How many clinical trials are testing Nabilone?
2 current trials in our USA and Canada registers name Nabilone as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Nabilone trials recruiting patients?
Yes. 2 of the 2 trials are recruiting: 1 with sites in USA and 1 with sites in Canada. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Nabilone clinical trials?
PleoPharma, Inc (1) and Sunnybrook Health Sciences Centre (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Nabilone works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Nabilone works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Nabilone (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.